LIFE AI CEO Tuan Cao Honored on Tatler Most Influential List 2025

The annual Tatler Most Influential List for Vietnam acknowledges leading figures, innovators, and changemakers across Asia and globally, and this year features the acclaimed Dr. Tuan Cao.

SINGAPORE, Nov. 21, 2025 – Following his company’s integration into the powered by Gen AI and NVIDIA, founder Dr. Tuan Cao has been included in the prestigious for Vietnam.

LIFE AI CEO Tuan Cao Named to Tatler Most Influential List 2025

This recognition offers a significant advantage for Dr. Cao and LIFE AI, as Tatler employs a comprehensive vetting process, acknowledging only visionaries who generate impact and foster growth that propels and molds Vietnamese society. Dr. Cao’s presence on the Tatler Most Influential List 2025 highlights his contributions to Vietnam and the wider Asian territory, while also showcasing the swift and extensive impact LIFE AI is achieving across the region.

Despite the global challenges encountered in 2025, notable progress continues across society and culture, with LIFE AI emerging as a trailblazer in artificial intelligence (AI) technology. The company has been assiduously working to revitalize a fractured healthcare system, one often characterized by a focus on profit over patient well-being.

Utilizing its AI-driven technological innovations, LIFE AI is reinstating the fundamental purpose of healthcare, facilitating a system where providers can genuinely prioritize patients’ lives more effectively – and even more profitably – shifting away from a model that benefits from illness. The company has made remarkable advancements in establishing an intelligent foundation for human health, thereby diminishing obstacles in healthcare product development and rendering the process ten times faster and ten times more economical.

A crucial factor in LIFE AI’s success in fulfilling its mission stems from its collaboration with over 100 corporate and institutional partners. These include research partnerships with scientists from esteemed universities such as Stanford, Cornell, and UCSF, in addition to an expansive hospital network throughout Asia. The company notably performed the largest genetic study on autism in Southeast Asia for $10,000, significantly less than the estimated $1M+, and assisted Kalbe Farma, Southwest Asia’s largest pharmaceutical company, in introducing a personalized stroke prevention product in just six weeks, rather than the initial 24-month schedule.

This remarkable acceleration – shrinking a standard 24-month development cycle to merely six weeks – alongside the establishment of Southeast Asia’s largest – has unequivocally showcased the dynamic capacity and capability of LIFE AI’s platform. This serves as just one illustration of how the company’s “AI-first model as a service” strategy is spearheading healthcare innovation in Vietnam and internationally.

The tangible positive impact of LIFE AI’s efforts, under Dr. Tuan Cao’s guidance, and its measurable beneficial effect on Vietnam’s healthcare sector, epitomize the type of innovation that aligns with Tatler’s mission of influence and impact, thereby validating Dr. Cao’s inclusion on this year’s Tatler Most Influential List. This distinction is shared by Dr. Cao and his team at LIFE AI, as well as all those committed to reinstating the authentic purpose of healthcare, with LIFE AI spearheading the development of genuine products that assist real patients during a period when the healthcare industry is most in need of its missing care.

“Inclusion on the Tatler Most Influential List represents a significant victory for both AI and the healthcare domain,” stated Dr. Tuan Cao, founder of LIFE AI. “I am deeply honored to be acknowledged alongside my pioneering peers and commend their remarkable contributions to their respective fields. It is a genuine privilege to be featured on this year’s list, and LIFE AI is committed to persistently advancing life care for everyone, driven by speed, scale, and innovation.”

About LIFE AI

LIFE AI, headquartered in Singapore, operates a foundational AI platform empowering businesses to expedite the launch of life science products, including precision health solutions and drug discoveries, from concept to market more quickly and affordably. The company is charting the future of health through the construction of the Intelligence Layer of Human Health – an innovative foundational infrastructure where human intelligence, AI computation, and impact-driven models converge within a progressive co-creation ecosystem.

| |

CONTACT: Media Contact
Yen Tran
yen@lifeai.io
Communications Lead, LIFE AI